EU drug regulator starts medical investigation of HPV vaccines

Written by Meghna A Singhania Published On 2015-07-14T12:29:29+05:30 | Updated On 14 July 2015 12:29 PM IST

To review the link of vaccines dosage to the complex regional pain syndrome, and POTS, but still recommends no changes in the shots of the medicine to treat cervical and womb cancer

The European medicine agency is a bit wary of cervical cancer vaccine links to two rare conditions of complex regional pain syndrome and POTS, a condition where the heart rate jumps abnormally after sitting or standing. However, the agency has not yet emphasized to cautiously use the vaccines against the HPV, used to treat over 70 million of cancer patients worldwide.

Current HPV vaccine information doesn't include warnings about these conditions and no causal link has been found ( AP).

Meghna A Singhania

Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751